image: Dr. Lancaster is a postdoctoral fellow in the Center for Traumatic Brain Injury Research at Kessler Foundation. Her research in social neuroscience focuses on understanding how people regulate their own emotions and perceive the emotions of others. view more
Credit: Kessler Foundation
EAST HANOVER, NJ. April 28, 2022. Kessler Foundation researchers have demonstrated the efficacy of a six-week interpersonal emotion regulation (IER) intervention for addressing the depression often experienced by individuals with multiple sclerosis (MS). The open access article, "Improving mental health in multiple sclerosis with an interpersonal emotion regulation intervention: A prospective randomized controlled trial," (DOI: 10.1016/j.msard.2022.103643 ) was epublished on January 30, 2022, by Multiple Sclerosis and Related Disorders.
This study, the first to provide Class 1 evidence of IER’s efficacy in the MS population, is an important step in addressing psychological comorbidities. The authors are Katie Lancaster, PhD, Sarah J. Thomson, PhD, Nancy Chiaravalloti, PhD, and Helen M. Genova, PhD, of Kessler Foundation. Link: https://tinyurl.com/u5asjkac
“Although most people are unfamiliar with the term ‘interpersonal emotion regulation,’ they are likely to use this strategy on a daily basis,” explained lead author Dr. Lancaster. “IER refers to the act of managing emotions by turning towards others. For example, if I’m upset, I could deal with that emotion independently by journaling or going for a run. Alternatively, I could use interpersonal strategies to improve my emotional state - e.g., venting to a loved one, asking for a hug, or distracting myself via a social event – some of the seemingly endless number of ways that we can manage emotions by leveraging our social connections.”
“Prior research has shown that these IER strategies are very powerful,” Dr. Lancaster added. “For instance, people who favor using IER strategies tend to be happier and have better physical health. And since these strategies are free and simple to use, we decided to design an intervention focused around using IER to improve mental health. We chose to test the intervention in people with MS.”
More than a third of people with MS have significant levels of depression and anxiety, which adversely affect daily life activities. These mental health issues tend to worsen over time, complicating the long-term treatment needed for this chronic neurological condition, according to Dr. Lancaster. “Given the scope of mental health issues in this population, researching effective interventions like IER that are low cost and accessible is a priority,” she said.
For the current study, the researchers randomly assigned a sample of individuals with MS to either the treatment or control groups. Participants in the treatment group worked with a trained interventionist to identify and implement personalized IER strategies over the course of six weeks. The control group met with the interventionist on the same schedule but did not modify the strategies that they typically used to regulate their emotions. Measured outcomes were depression, stress, quality of life, and self-reported social support. At follow up, depression levels had significantly decreased in the IER intervention group, while depression levels in the control group remained unchanged over the course of the study.
“Our results show that as a low cost, easily implemented intervention that can be tailored to the individual, IER can add an important dimension to conventional mental health therapies,” Dr. Lancaster summarized. “There are implications for other populations, as well. Because this IER intervention targets the basic mental process of emotion regulation, it has the potential to improve well-being in other conditions characterized by emotion dysregulation.”
Funding: New Jersey Health Foundation (PC 8-19)
Learn more about ongoing studies for MS and other conditions at Join Our Research Studies | Kessler Foundation. Inquire about research participation at: ResearchStudies@kesslerfoundation.org
About Kessler Foundation
Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility, and long-term outcomes, including employment, for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.
Stay Connected
Twitter | http://Twitter.com/KesslerFdn
Facebook | http://Facebook.com/KesslerFoundation
YouTube | http://Youtube.com/user/KesslerFoundation
Instagram | http://Instagram.com/kesslerfdn
iTunes & SoundCloud | http://Soundcloud.com/kesslerfoundation
To interview an expert, contact:
Deborah Hauss, DHauss@kesslerfoundation.org;
Carolann Murphy, CMurphy@KesslerFoundation.org.
Title: Katie Lancaster, PhD
Caption: Dr. Lancaster is a postdoctoral fellow in the Center for Traumatic Brain Injury Research at Kessler Foundation. Her research in social neuroscience focuses on understanding how people regulate their own emotions and perceive the emotions of others.
Journal
Multiple Sclerosis and Related Disorders
Method of Research
Randomized controlled/clinical trial
Subject of Research
People
Article Title
Improving mental health in multiple sclerosis with an interpersonal emotion regulation intervention: A prospective randomized controlled trial
Article Publication Date
30-Jan-2022
COI Statement
none